ObsEva SA (OBSV)

2.47 -0.08  -3.14% NASDAQ Jul 23, 20:00 USD
View Full Chart
Price Chart
View All OBSV News

News

View All Events

Events

Date Type Description
08/06/2021 Earnings Results Q2 2021 Earnings Results
05/28/2021 AGM 2020 Annual General Meeting
05/06/2021 Earnings Results Q1 2021 Earnings Results
03/05/2021 Earnings Results Q4 2020 Earnings Results
11/05/2020 Earnings Results Q3 2020 Earnings Results
08/06/2020 Earnings Results Q2 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: ObsEva SA is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. The company is focused on providing therapeutic solutions for women between the ages of 15 and 49 who suffer from reproductive health conditions that affect their quality of life, ability to conceive or that complicate pregnancy and the health of newborns. The is developing OBE2109 as a novel, oral gonadotropin-releasing hormone, or GnRH, receptor antagonist, for the treatment of pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women.
  • URL: https://www.obseva.com
  • Investor Relations URL: N/A
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Value
  • Next Earnings Release: Aug. 06, 2021
  • Last Earnings Release: May. 06, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.